Randomized , double-blind trial ( treatment period , @ months ; median follow-up , @ months ) ; @ adult patients who had experienced a first episode of symptomatic unprovoked pulmonary embolism ( ie , with no major risk factor for thrombosis ) and had been treated initially for @ uninterrupted months with a vitamin K antagonist were randomized and followed up between July @ and September @ in @ French centers .